Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

AI predicts patient payments following online doctor visits

When it comes to getting paid patients’ portions for online medical consultations, physicians do better to engage patients attentively and provide high-quality service during the virtual visits than to rely on their standing reputations.

Thumbnail

The best 50 healthcare providers based on supply chain excellence

GHX has awarded the best 50 healthcare organizations based on supply chain excellence.

Thumbnail

Private equity continues to snap up physician groups

Private equity firms are continuing their investments in physician practices, scooping up 355 acquisitions from 2013 to 2016, according to a new study published in JAMA.

Thumbnail

Cerner hires new execs, extends Intermountain Healthcare partnership

Cerner Corporation, a health information and EHR technology company, has extended its partnership with not-for-profit healthcare company Intermountain Healthcare in a multiyear agreement.

Thumbnail

Hedge funds distance themselves from Purdue Pharma

The troubles of Purdue Pharma, the maker of the opioid OxyContin, have led two hedge funds to cut ties with the company as legal consequences from the national opioid abuse and overdose epidemic continue to play out.

Thumbnail

Marketers using personal Medicare under investigation

A new investigation examining how marketers are getting the personal Medicare information of seniors is underway, with government watchdogs wanting to know if a misuse of a government system is to blame, The Associated Press reported.

HHS teams up with Janssen to treat coronavirus

HHS is extending its existing partnership with pharmaceutical company Janssen Research & Development, which is part of Johnson & Johnson, to develop treatments for the 2019 novel coronavirus, the agency announced.

 

Thumbnail

Unregulated Craiglist drug market rising due to sky-high prices

More Americans afflicted with chronic disease are turning to unregulated markets such as Craigslist to find insulin and other necessary medications because they can’t afford to purchase them at the pharmacy­­.

 

Displaying 2177 - 2184 of 8456

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.